FDA Import Refusal 799-4276505-9/11/3 — Globela Pharma Pvt Ltd.
The FDA refused shipment 799-4276505-9/11/3 from Globela Pharma Pvt Ltd. (India) on Nov 22, 2024. The refused product falls under Drugs and Biologics — FEBUXOSTAT (XANTHINE OXIDASE INHIBITOR). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Nov 22, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66TCC03 FEBUXOSTAT (XANTHINE OXIDASE INHIBITOR)
- Charges
- 75